Articles
Sex keeps your genome clean
When sexual species reproduce asexually, they accumulate bad mutations at an increased rate, report two Indiana University evolutionary biologists. The researchers used the model species Daphnia pulex, or water flea, for their studies
[ + ]Using aromatic selectivity to facilitate difficult separations
Typical alkyl-bonded reversed phase columns (C18 and C8) do not always offer the necessary selectivity needed to separate complex mixtures. In many cases, high pH mobile phases and ion-pairing reagents may be required to obtain critical separations
[ + ]Grain protein composition in a hurry
The protein composition of a seed contains a wealth of information about its identity. This information can have great commercial benefit, but this is only fully realised if the information is provided within a short time
[ + ]Growth opportunities for nucleic acid purification and amplification technologies
The expiry of the Polymerase Chain Reaction Patent should foster the development of a range of innovative tests and kits and lead to a reduction in the costs of PCR reagents and instrumentation
[ + ]HealthLinx and Cryptome embark on a future together
The first merger of 2006 has created new opportunities in the hot field of theranostics. Ruth Beran talks with its architects about the merged company and its future plans. [ + ]
CSL plots its future course with R&D
To no one's surprise, CSL has become the dominant force in the Australian biotechnology sector. Graeme O'Neill learns from CSL's chief scientist, Andrew Cuthbertson, about the solid research that will drive the company in the next few years. [ + ]
Scientific advances boost anti-doping campaign
The unprecedented anti-doping campaign for the 2006 Commonwealth Games in Melbourne is aimed at making these Games the cleanest ever with thousands of tests being carried out on athletes in Australia and overseas
[ + ]Microscope allows the tracking of a functioning protein
A Stanford University research team has designed the first microscope sensitive enough to track the real-time motion of a single protein down to the level of its individual atoms
[ + ]Narhex boss sets out path to market
Sydney-based Narhex has begun recruiting for an early-stage trial of an HIV drug. Helen Schuller spoke with the company's MD, John Mills, about HIV drug development, working in China, and good management. [ + ]
Kidney stone analysis using FTIR spectrometry
A Kidney Stone Library & Analysis Kit has been developed to assist in the identification and characterisation of kidney stones by spectral analysis
[ + ]Differential cell sorting speeds sample preparation
Researchers at Sandia National Laboratories in California have developed an enhancement to a dielectrophoresis system that they say could revolutionise the way biological sample preparation is conducted
[ + ]A way around a problem
Biotechnology has provided a solution to the problem of how to get science to the market without compromising research, writes editor-in-chief Iain Scott. [ + ]
Facing up to commercial reality
The research community is becoming more sophisticated in the way they approach intellectual property and industry partnerships. Ruth Beran looks at how technology transfer has changed, where it is going and the challenges it faces. [ + ]
Big pharma's partnering plans
Pfizer's Peter Corr told the AusBiotech 2005 conference that big pharma and biotech are part of a delicate ecosystem -- and both have key roles to play. [ + ]
'Without partners, you are dead'
US venture capitalist Osagie Imasogie told AusBiotech 2005 that biotech companies need to get aggressive when it comes to finding opportunities. [ + ]